Filing Details

Accession Number:
0001628280-24-046753
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-08 18:00:55
Reporting Period:
2024-11-06
Accepted Time:
2024-11-08 18:00:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611311 P. David Rosenbaum C/O Ardelyx, Inc.
400 Fifth Avenue, Suite 210
Waltham MA 02451
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-06 27,171 $2.32 180,787 No 4 M Indirect By Wife
Common Stock Disposition 2024-11-06 27,171 $6.10 153,616 No 4 S Indirect By Wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By Wife
No 4 S Indirect By Wife
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-11-06 27,171 $0.00 27,171 $2.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2029-01-17 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 301,946 Direct
Common Stock 77,592 Indirect Family Trust
Footnotes
  1. The shares are directly held by the Reporting Person's wife.
  2. The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
  3. The option became exercisable as it vested and the shares subject to the option vested in 48 successive, equal monthly installments on each monthly anniversary of January 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.